Spyre Therapeutics announces proposed public offering of common stock (SYRE:NASDAQ)
· seekingalpha.com
Spyre Therapeutics (SYRE) launches a public stock offering to fund clinical trials and SPY072 development.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...